{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T09:07:34Z","timestamp":1788772054857,"version":"build-2803163510"},"reference-count":13,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Biochemistry"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.clinbiochem.2026.111179","type":"journal-article","created":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T05:53:00Z","timestamp":1785995580000},"page":"111179","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Unexpected increase in false-positive results following benzodiazepine immunoassay reformulation"],"prefix":"10.1016","volume":"145","author":[{"given":"Chelsea B.","family":"Swartchick","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine L.H.","family":"Snozek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian Triana","family":"Dopico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin J.","family":"Kaleta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinbiochem.2026.111179_bb0005","series-title":"StatPearls. Treasure Island (FL)","article-title":"Benzodiazepines","author":"Bounds","year":"2026"},{"key":"10.1016\/j.clinbiochem.2026.111179_bb0010","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.drugalcdep.2019.02.033","article-title":"The epidemiology of benzodiazepine misuse: a systematic review","volume":"200","author":"Votaw","year":"2019","journal-title":"Drug Alcohol Depend."},{"issue":"2","key":"10.1016\/j.clinbiochem.2026.111179_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.trre.2022.100694","article-title":"Substance use screening in transplant populations: recommendations from a consensus workgroup","volume":"36","author":"Jowsey-Gregoire","year":"2022","journal-title":"Transplant Rev. (Orlando)"},{"issue":"1","key":"10.1016\/j.clinbiochem.2026.111179_bb0020","doi-asserted-by":"crossref","first-page":"66","DOI":"10.4065\/83.1.66","article-title":"Urine drug screening: practical guide for clinicians","volume":"83","author":"Moeller","year":"2008","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.clinbiochem.2026.111179_bb0025","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jmsacl.2023.02.010","article-title":"Comparison of two highly sensitive benzodiazepine immunoassay lab developed tests for urine drug testing in clinical specimens","volume":"28","author":"Lund","year":"2023","journal-title":"J. Mass Spectrom. Adv. Clin. Lab."},{"issue":"2","key":"10.1016\/j.clinbiochem.2026.111179_bb0030","first-page":"214","article-title":"Benzodiazepine pharmacology and central nervous system-mediated effects","volume":"13","author":"Griffin","year":"2013","journal-title":"Ochsner J."},{"issue":"4","key":"10.1016\/j.clinbiochem.2026.111179_bb0035","first-page":"359","article-title":"KIMS, CEDIA, and HS-CEDIA immunoassays are inadequately sensitive for detection of benzodiazepines in urine from patients treated for chronic pain","volume":"17","author":"Darragh","year":"2014","journal-title":"Pain Physician"},{"key":"10.1016\/j.clinbiochem.2026.111179_bb0040","series-title":"Benzodiazepines Plus Assay Package Insert","author":"Roche Diagnostics","year":"2023"},{"key":"10.1016\/j.clinbiochem.2026.111179_bb0045","series-title":"Benzodiazepines II Assay Package Insert","author":"Roche Diagnostics","year":"2024"},{"key":"10.1016\/j.clinbiochem.2026.111179_bb0050","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jmsacl.2024.06.002","article-title":"Despite the improved clinical sensitivity of the Roche benzodiazepines II assay it cannot replace mass spectrometry in all patient populations","volume":"33","author":"Tolan","year":"2024","journal-title":"J. Mass Spectrom. Adv. Clin. Lab."},{"issue":"6","key":"10.1016\/j.clinbiochem.2026.111179_bb0055","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1093\/jalm\/jfae083","article-title":"Evaluation of a benzodiazepine immunoassay for urine drug testing in clinical specimens","volume":"9","author":"Ge","year":"2024","journal-title":"J. Appl. Lab. Med."},{"key":"10.1016\/j.clinbiochem.2026.111179_bib61","series-title":"Amphetamines II Assay Package Insert","author":"Roche Diagnostics","year":"2024"},{"key":"10.1016\/j.clinbiochem.2026.111179_bb0060","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.clinbiochem.2019.11.010","article-title":"The challenge that chlorine presented during the development of a benzodiazepine assay","volume":"76","author":"Lahr","year":"2020","journal-title":"Clin. Biochem."}],"container-title":["Clinical Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912026001128?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912026001128?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T08:08:07Z","timestamp":1788768487000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009912026001128"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":13,"alternative-id":["S0009912026001128"],"URL":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2026.111179","relation":{},"ISSN":["0009-9120"],"issn-type":[{"value":"0009-9120","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Unexpected increase in false-positive results following benzodiazepine immunoassay reformulation","name":"articletitle","label":"Article Title"},{"value":"Clinical Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2026.111179","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111179"}}